Follow Us Here:

Cancer Knowledge Network

Cancer Knowledge Network and Current Oncology are proudly published by Multimed Inc.
0
Menu
Advocate - Educate - Innovate

Tag Archives: cancer screening

An Advocate for the Previvor Community: Introducing Georgia Hurst

GeorgiaHurst

Georgia Hurst

by Dr. Robin McGee, CKN Patient Advocacy Editor

 

Georgia Hurst had a life before advocacy. She was a fit, active mother, putting the finishing touches on her Master’s thesis in Post-War II American History at Northwestern when she learned her brother had been diagnosed with colon cancer at 48.  Several years before, they lost an older brother to colon cancer at 36.  This early-onset pattern prompted healthcare providers to suggest she be tested for Lynch syndrome (Ls), an autosomal dominant genetic condition which strongly predisposes one to endometrial and colorectal cancer, and various other cancers.  She tested positive, and her world changed.

 

Continue reading

Breast cancer screening panels continue to confuse the facts and inject their own biases

breastcancerby D.B. Kopans, MD, Breast Imaging Division, Department of Radiology, Massachusetts General Hospital, Avon Comprehensive Breast Center, Boston

Perspectives in Oncology, originally printed in Current Oncology 

 

Additional confusion has been added to the “debate” about breast cancer. Women, their doctors, and the media are being misled, and women will die, unnecessarily, as a result. I recently outlined the scientific errors that I was concerned would be made by the U.S. Preventive Services Task Force (USPSTF) and the International Agency for Research on Cancer (IARC) panels in their reviews of breast cancer screening guidelines. Based on the draft proposal by the USPSTF, and now IARC, my concerns have been realized. Because the panels include few (if any) experts in screening, they are unable to sort out the validity of the various analyses involved, and they give credibility to analyses that have major flaws.

One of the other major problems with the panels is that their deliberations are held in secret. If anything should be completely transparent, it should be discussions of health care guidelines. It is my understanding that the IARC panel did not unanimously agree, and that a number of panel members felt that the data supported screening women starting at the age of 40. There should be transparency, and IARC should provide full disclosure, as well as any minority reports.

Continue Reading….


New York Times Article: In Israel, a Push to Screen for Cancer Gene Leaves Many Conflicted

Photo Credit:  Rina Castelnuovo for The New York Times

Photo Credit: Rina Castelnuovo for The New York Times

This article was originally printed in the New York Times.

(Isreal) has one of the highest rates of breast cancer in the world, according to a World Health Organization report. And some leading scientists here are advocating what may be the first national screening campaign to test women for cancer-causing genetic mutations common among Jews — tests that are already forcing young women to make agonizing choices about what they want to know, when they want to know it and what to do with the information.  Read more…